Presentation slides and video from the 2018 Advances in Cancer Immunotherapy™ - Boston, MA held on September 27, 2018 are available here.Program Organizers
Program Summary
Specifically designed by the Society for Immunotherapy of Cancer (SITC) for clinical oncologists, registered nurses, nurse practitioners, pharmacists, emergency physicians and the entire cancer care team, the Advances in Cancer Immunotherapy™ (ACI) programs are introductory, CME-, CPE-, CNE-, MOC-certified programs. Presented by leading and local authorities in tumor immunology and cancer immunotherapy, these programs will facilitate understanding of:
Disclaimer: Due to the rapidly-evolving field of cancer immunotherapy, some of the content on this page may be out of date. For current information from SITC on cancer immunotherapy, please visit connected.sitcancer.org.
Meeting: Advances in Cancer Immunotherapy™- Boston, MA; Session II: Immunotherapy in Practice; Concurrent Session 1 - Presentation: Immunotherapy for the Treatment of Hematologic Malignancies; Presenter: Myrna R. Nahas, MD - Beth Israel Deaconess Medical Center; Date: September 27, 201800:42:15
Meeting: Advances in Cancer Immunotherapy™- Boston, MA; Session II: Immunotherapy in Practice; Concurrent Session 1 - Presentation: Immunotherapy for the Treatment of Genitourinary Malignancies; Presenter: Kathleen Mahoney, MD, PhD - Beth Israel Deaconess Medical Center; Date: September 27, 201800:35:33
Meeting: Advances in Cancer Immunotherapy™- Boston, MA; Session II: Immunotherapy in Practice; Concurrent Session 1 - Presentation: Immunotherapy for the Treatment of Head and Neck Cancer; Presenter: Glenn J. Hanna, MD - Dana-Farber Cancer Institute; Date: September 27, 201800:40:17
Meeting: Advances in Cancer Immunotherapy™- Boston, MA; Session II: Immunotherapy in Practice; Concurrent Session 1 - Presentation: Immunotherapy for the Treatment of Lung Cancer; Presenter: Deepa Rangachari, MD - Beth Israel Deaconess Medical Center; Date: September 27, 201800:34:30
Meeting: Advances in Cancer Immunotherapy™- Boston, MA; Session II: Immunotherapy in Practice; Concurrent Session 1 - Presentation: Immunotherapy for the Treatment of Melanoma; Presenter: Elizabeth Buchbinder, MD - Dana-Farber Cancer Institute; Date: September 27, 201800:30:42
Meeting: Advances in Cancer Immunotherapy™- Boston, MA; Session I: Introduction to Cancer Immunotherapy: Presentation: Basic Principles of Cancer Immunotherapy; Presenter: Patrick A. Ott, MD, PhD - Dana-Farber Cancer Institute, Harvard Medical School; Date: September 27, 201800:38:46
Meeting: Advances in Cancer Immunotherapy™- Boston, MA; Session IV: The Future of Cancer Immunotherapy; Presentation: What's Next for Cancer Immunotherapy?; Presenter: Ryan J. Sullivan, MD - Massachusetts General Hospital; Date: September 27, 201800:27:41
Meeting: Advances in Cancer Immunotherapy™- Boston, MA; Session III: Immunotherapy after Practice; Presentation: Practical Barriers in Cancer Immunotherapy Treatment; Presenter: Virginia Seery, MSN, RN, ANP-BC - Beth Israel Deaconess Medical Center; Date: September 27, 201800:18:29
Meeting: Advances in Cancer Immunotherapy™- Boston, MA; Session III: Immunotherapy after Practice; Presentation: Panel Discussion; Presenters: Virginia Seery, MSN, RN, ANP-BC - Beth Israel Deaconess Medical Center, Alexandra S. Bailey, MD – Dana-Farber Cancer Institute, Rebekah A. Hartwell, PharmD, BCPS, BCOP – Beth Israel Deaconess Medical Center; Date: September 27, 201800:14:17